WASHINGTON--(BUSINESS WIRE)--April 3, 2006--ImClone Systems Incorporated (NASDAQ: IMCL - News) presented pre-clinical data highlighting progress made in the development of several pre-clinical and clinical-stage antibody research programs at the 97th Annual Meeting of the American Association for Cancer Research (AACR) currently being held in Washington, D.C.
